Compound Evidence File
#EC-2026-0879
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg)
Filed under Injectable Oils. The bureau holds 141 laboratory returns for this compound from 58 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
58 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 17 Jan 2026 | 1 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Jan 2026 | 11 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Jun 2026 | 19 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Jan 2026 | 11 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Apr 2026 | 10 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Mar 2026 | 11 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Jul 2026 | 14 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jun 2026 | 6 Jul 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 3 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 1 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Feb 2026 | 9 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Nov 2025 | 23 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Dec 2025 | 9 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Apr 2026 | 12 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 15 Apr 2026 | 5 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 21 Jun 2026 | 27 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 17 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Jul 2026 | 15 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Feb 2026 | 6 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Apr 2026 | 12 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Dec 2025 | 13 Aug 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 9.5 | 9.5 | 9.5 | 25 Apr 2025 | 25 Apr 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.3 | 8.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 9.1 | 7.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 | 21 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.4 | 7.6 | 10.0 | 23 May 2026 | 23 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 5 | 8.3 | 7.0 | 10.0 | 28 Mar 2025 | 23 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 1 | 8.2 | 8.2 | 8.2 | 3 Jul 2025 | 3 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.1 | 7.9 | 8.5 | 21 May 2026 | 21 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 8.0 | 8.0 | 8.0 | 14 Jan 2025 | 14 Jan 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 7.7 | 7.7 | 7.7 | 11 Jun 2025 | 11 Jun 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 2 | 7.5 | 6.9 | 8.1 | 25 Apr 2025 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.3 | 6.9 | 7.7 | 23 May 2026 | 23 May 2026 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 7.3 | 7.3 | 7.3 | 3 Jun 2025 | 3 Jun 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 4 | 7.2 | 5.4 | 8.5 | 17 Dec 2024 | 26 Jan 2026 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 3 | 6.5 | 5.8 | 7.3 | 2 Apr 2025 | 26 Jan 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 | 2 Apr 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 6.4 | 6.4 | 6.4 | 24 Apr 2025 | 24 Apr 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 | 6 May 2025 |
| Xingruida XDRCASE #VI-2026-0898 | X | 4 | 5.5 | 4.6 | 6.0 | 21 May 2025 | 20 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 5.5 | 3.3 | 7.8 | 3 Jun 2025 | 25 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 5.5 | 5.5 | 5.5 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 5.3 | 5.3 | 5.3 | 13 Jun 2025 | 13 Jun 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 4.8 | 3.8 | 5.7 | 2 Apr 2025 | 19 Jan 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 4.8 | 4.8 | 4.8 | 8 Jul 2025 | 8 Jul 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 4.2 | 2.9 | 5.5 | 2 Jul 2025 | 24 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 1 | 4.2 | 4.2 | 4.2 | 8 Jul 2025 | 8 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 4.2 | 4.2 | 4.2 | 14 Jan 2025 | 14 Jan 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 4.0 | 4.0 | 4.0 | 3 Jun 2025 | 3 Jun 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 3.4 | 3.4 | 3.4 | 16 Mar 2025 | 16 Mar 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
Open any subject to view the batch-level evidence for Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) alone.